Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - ferrous fumarate, quantity: 310 mg; folic acid, quantity: 0.35 mg - tablet, film coated - excipient ingredients: hypromellose; magnesium stearate; titanium dioxide; microcrystalline cellulose; purified talc; iron oxide red; sodium starch glycollate type a; povidone; colloidal anhydrous silica; triethyl citrate - to be given as a source of iron and folic acid for the prevention and treatment of iron and folic acid deficiency anaemias. it may also be used for the prevention and treatment of these conditions during pregnancy.

United States - English - NLM (National Library of Medicine)

nnodum pharmaceuticals - ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - ferrous cation 151 mg - for the treatment of all anemias responsive to oral iron therapy, such as hypochromic anemia associated with pregnancy, chronic or acute blood loss, dietary restriction, metabolic disease and post-surgical convalescence. hemochromatosis and hemosiderosis are contraindications to iron therapy. folic acid is contraindicated in patients with pernicious anemia (see precautions). soybean oil, lecithin, di calcium phosphate anhydrous, beeswax yellow, hydrogenated soybean oil.

United States - English - NLM (National Library of Medicine)

nnodum pharmaceuticals - ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - ferrous cation 66 mg - for the treatment of all anemias responsive to oral iron therapy, such as hypochromic anemia associated with pregnancy, chronic or acute blood loss, dietary restriction, metabolic disease and post-surgical convalescence. hemochromatosis and hemosiderosis are contraindications to iron therapy. folic acid is contraindicated in patients with pernicious anemia (see precautions).

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - ferrous fumarate, quantity: 310 mg; folic acid, quantity: 0.35 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; hypromellose; iron oxide red; magnesium stearate; microcrystalline cellulose; povidone; purified talc; sodium starch glycollate type a; titanium dioxide; triethyl citrate - to be given as a source of iron and folic acid for the prevention and treatment of iron and folic acid deficiency anaemias. it may also be used for the,prevention and treatment of these conditions during pregnancy.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - ferrous fumarate, quantity: 310 mg; folic acid, quantity: 0.35 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate type a; colloidal anhydrous silica; povidone; purified talc; hypromellose; titanium dioxide; iron oxide red; magnesium stearate; triethyl citrate - source of iron and folic acid for the prevention and treatment of iron and folic acid deficiency anaemias, including pregnancy.

United States - English - NLM (National Library of Medicine)

avion pharmaceuticals, llc - ferrous bisglycinate (unii: sfw1d987qv) (ferrous cation - unii:gw89581owr), ferrous asparto glycinate (unii: h7426rgb3l) (ferrous cation - unii:gw89581owr), ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), biotin (unii: 6so6u10h04) (biotin - unii:6so6u10h04), cupric oxide (unii: v1 - ferrous cation 36.7 mg - indications: feriva fa ® is a multivitamin/multimineral dietary supplement indicated for use in improving the nutritional status of patients with iron deficiency. contraindications: feriva fa ® is contraindicated in patients with a known hypersensitivity to any of the ingredients. hemochromatosis and hemosiderosis are contraindicated to iron therapy. pediatric use: safety and effectiveness have not been studied in pediatric patients.

United States - English - NLM (National Library of Medicine)

avion pharmaceuticals, llc - ferrous asparto glycinate (unii: h7426rgb3l) (ferrous cation - unii:gw89581owr), ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), levomefolic acid (unii: 8s95dh25xc) (levomefolic acid - unii:8s95dh25xc), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), zinc (unii: j41csq7qds) (zinc - unii:j41csq7qds), intrinsic factor (unii: 70bt6oqt2q) (intrinsic factor - unii:70bt6oqt2q) - ferrous cation 25 mg - indications: chromagen™ is a multivitamin/multimineral dietary supplement indicated for use in improving the nutritional status of patients with iron deficiency. contraindications : chromagen™ is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Kenya - English - Pharmacy and Poisons Board

jenburkt pharmaceuticals ltd nirmala apartments93jay prakash road andheri - ferrous fumarate folic acid ascorbic acid… - capsule - ferrous fumarate bp 300 mg folic acid bp 1.5 mg… - antianemic preparations - iron preparations: iron

United States - English - NLM (National Library of Medicine)

jaymac pharmaceuticals llc - folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), ferrous fumarate (unii: r5l488ry0q) (iron - unii:e1uol152h7), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate (unii: 9e8x80d2l0) (.alpha.-tocopherol - unii:h4n855pnz1), thiamine mononitrate (unii: 8k0i04919x) (thiamine - unii:x66nso3n35), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), pyridoxine hydrochlorid - folic acid 1 mg - viva® ct prenatal chewable is indicated for the distinct nutritional requirements of individuals in need of prenatal/postnatal dietary supplementation as determined by a licensed medical practitioner. this product can be used fordietary management prior to conception. viva® ct prenatal chewable should be administered under the supervision of a licensed medical practitioner. viva® ct prenatal chewable is contraindicated in individuals with a known hypersensitivity to any of the ingredients.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - ferrous fumarate - oral solution - 28mg/1ml